• Bayer to commercialise Daré’s monthly contraceptive Ovaprene in US pharmaceutical-business-review
    January 15, 2020
    Bayer has entered into a licence agreement with Daré Bioscience to commercialise investigational contraceptive product called Ovaprene in the US.
  • Daré to merge with Pear Tree Pharma biospectrumasia
    May 09, 2018
    Agreement intends to broaden Company’s product portfolio within women’s reproductive health with novel clinical candidate, positioning Company with first in class candidates in contraception, sexual health and vaginal health
PharmaSources Customer Service